文献速递胃肠外科围术期管理与 ERAS

McKeown微创食管切除术中腹腔镜空肠造瘘:倾向性评分分析

Laparoscopic jejunostomy during McKeown minimally invasive esophagectomy: a propensity score analysis.
PubMed 文献 · Surg Endosc · 2025-01-17

本研究为单中心回顾性研究,纳入577例接受McKeown微创食管切除术的食管鳞癌患者,经倾向性评分匹配后每组149例,比较术中放置空肠造瘘管与常规鼻肠管喂养的结局。结果显示空肠造瘘组术后住院时间更短、围术期白蛋白丢失率更低、术后肺炎和胸腔积液发生率更低,吻合口漏发生率无显著差异;在发生吻合口漏的患者中,空肠造瘘组围术期白蛋白丢失率和再入院率显著更低。

要点

  • McKeown微创食管切除术中腹腔镜空肠造瘘安全可行。
  • 空肠造瘘可缩短术后住院时间并降低围术期白蛋白丢失率。
  • 空肠造瘘降低术后肺炎和胸腔积液发生率,不增加吻合口漏。

核心结论

  • McKeown微创食管切除术中行腹腔镜空肠造瘘安全可行,并有助于吻合口漏的恢复。

研究设计与样本

  • 单中心回顾性研究,纳入577例连续接受McKeown微创食管切除术的食管鳞癌患者,按是否术中放置空肠造瘘管分组,采用倾向性评分匹配使基线一致。

主要发现

  • 匹配后每组各149例,空肠造瘘组术后住院时间短于鼻肠管组(11d vs 9d,P=0.002)。
  • 空肠造瘘组围术期白蛋白丢失率低于鼻肠管组(0.17 vs 0.13,P=0.023)。
  • 空肠造瘘组术后肺炎发生率低于鼻肠管组(23 vs 3,P<0.001),胸腔积液发生率亦更低(16 vs 5,P=0.027)。
  • 两组吻合口漏发生率无显著差异;在发生吻合口漏的患者中,空肠造瘘组围术期白蛋白丢失率更低(0.20(0.14-0.26) vs 0.12(0.08-0.16),P=0.03),再入院率更低(8(40.0) vs 2(7.4),P=0.019)。

临床怎么用

  • 在McKeown微创食管切除术中可考虑行腹腔镜空肠造瘘以改善术后营养支持与恢复。

局限性

  • 本研究为单中心回顾性研究,结论需进一步前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nutrition is a key factor limiting the rapid recovery of patients undergoing esophagectomy, but there is as yet no consensus on the optimal route of nutritional support. This study aimed to evaluate the potential benefits of laparoscopic jejunostomy (Lap-J) in comparison to conventional nasoenteral tube (NT) feeding in patients who underwent McKeown minimally invasive esophagectomy (MIE). METHODS: A total of 577 consecutive patients with esophageal squamous cell carcinoma (ESCC) who underwent McKeown MIE were included in this single-center retrospective study. They were divided into two groups based on whether or not an intraoperative jejunostomy tube (JT) was placed, and baseline information was made consistent between the 2 groups using propensity score matching (PSM). RESULTS: After exclusion and matching, 149 patients were included in each of the 2 groups. Compared with NT, patients who received JT had a shorter postoperative length of stay (11d vs 9d, P = 0.002), lower perioperative albumin loss rate (0.17 vs 0.13, P = 0.023), and lower rates of postoperative pneumonia (23 vs 3, P < 0.001) and pleural effusion (16 vs 5, P = 0.027). There was no significant difference in the occurrence of anastomotic leakage (AL) between the 2 groups. But in the group of patients with AL, the jejunostomy group had a significantly lower rate of perioperative albumin loss (0.20 (0.14-0.26) vs 0.12 (0.08-0.16) P = 0.03) and readmission (8 (40.0) vs. 2 (7.4) P = 0.019). CONCLUSIONS: Lap-J during the McKeown MIE has demonstrated good safety and feasibility, and it contributes to the recovery of AL, making its outcome safe and simple. TRIAL REGISTRATION: National clinical trials registry: NCT06192212, registered January 4th, 2024.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Pu XS, Bao T, Wang YJ, et al. Laparoscopic jejunostomy during McKeown minimally invasive esophagectomy: a propensity score analysis. Surg Endosc. 2025. PMID: 39821455. doi:10.1007/s00464-024-11519-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。